Larvol Delta - Safety-and-immunogenicity-of-a-multivalent-HIV-vaccine-comprising-envelope-protein-with-either-DNA-or-NYVAC-vectors-HVTN-096-a-phase-1b-doubleblind-placebocontrolled-trial

multi-gene HIV alphavaccine product - AlphaVax

http://www.ncbi.nlm.nih.gov/pubmed/31601541

Oct 12, 2019

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next